Suppression of adverse reactions by big Pharma?
Glaxo got more bad news on the Avandia front when a Congressional Committee Report found that company executives made a concerted effort to intimidate Dr. John Buse, a diabetes expert, into keeping quiet about some of the Avandias safety problems. The report alleged that Glaxo Chief Executive Jean-Pierre Garnier and former research chief Tachi Yamada were involved in the intimidation.
Avandia was once Glaxos second biggest selling drug, but sales in the US dropped 48% after the Cleveland Clinic published its heart attack study.
Big Pharma price fixing?
Schering- Plough Pays $31 Million to Resolve Pharmaceutical Fraud Allegations
The State of Missouri filed a lawsuit against Schering-Plough in May 2005 and alleged in its complaint that the company did not accurately report drug prices for drugs sold to pharmacies involved in the Missouri Medicaid program. This is the largest settlement figure the State of Missouri has ever recovered in a pharmaceutical pricing fraud. This is one of a number of lawsuits filed by state AGs office against pharmaceutical companies alleging pharmaceutical fraud. They typically follow qui tam lawsuit fact patterns.